About Biochem Pharmaceutical Industries Limited Part IX
Data last updated:
Biochem Pharmaceutical Industries Limited Part IX was a public limited company based in Ahmedabad, Gujarat, India, operated as a subsidiary of Cadila Healthcare Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 November 2004.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2004PLC094323. The company has 28 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹12 Cr and a paid-up capital of ₹7.5 Cr. It was led by directors including Bhavana Sharadchandra Doshi and Ganesh Narayan Nayak.
Its last annual general meeting (AGM) was held on 04 August 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at Zydustower Satellitecrossroad Sarkhej – Gandhinagarhighway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2016, the company reported a revenue of ₹366.61 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹11.1 Cr (net margin 3%) and EBITDA of ₹24.61 Cr (EBITDA margin 6.7%).
As per MCA filings, the company had open charges of ₹40 Cr and satisfied charges of ₹13.85 Cr on record. Court records list 64 cases involving the company, including 46 filed by the company and 18 filed against it; 8 cases are pending.
The last known website on record is biochemgroup.com.
Company details
CIN history
Biochem Pharmaceutical Industries Limited Part IX has one previous CIN (Corporate Identification Number): U24230MH2004PLC149397. The current CIN is U24230GJ2004PLC094323, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ2004PLC094323 | Current |
| U24230MH2004PLC149397 | Previous |
Contact details
Biochem Pharmaceutical Industries Limited Part IX's registered office is in Ahmedabad, Gujarat.
- Registered AddressZydustower Satellitecrossroad Sarkhej – Gandhinagarhighway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biochem Pharmaceutical Industries Limited Part IX is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Financials of Biochem Pharmaceutical Industries Limited Part IX
FY 2016 filings availableBiochem Pharmaceutical Industries Limited Part IX reported revenue of ₹366.61 Cr (up 15% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year. EBITDA fell 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹24.61 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹11.1 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 6.7% | |
| Net Profit Margin | 3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Board of directors of Biochem Pharmaceutical Industries Limited Part IX
Biochem Pharmaceutical Industries Limited Part IX has 6 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavana Sharadchandra Doshi | Director | 13 Jan 2015 | 11 Years 9 Months | As last reported |
| Ganesh Narayan Nayak Also directs: Zydus Wellness Limited, Zydus Lifesciences Limited, Zydus Hospira Oncology Private Limited and 3 more | Director | 21 Dec 2011 | 14 Years 10 Months | As last reported |
| Anilkumar Matai | Director | 10 Nov 2014 | 11 Years 11 Months | As last reported |
| Deevyesh Jagjivan Radia | Director | 13 Jan 2015 | 11 Years 9 Months | As last reported |
| Mayank Jashwantlal Shah Also directs: Vidhi Research & Development LLP, MJ Shah Realtors LLP, Mauli Hotel Ventures LLP and 5 more | Director | 04 Nov 2004 | 21 Years 11 Months | As last reported |
| Nitinkumar Dalsukhray Parekh Also directs: Newleaf Consultants LLP | Director | 21 Dec 2011 | 14 Years 10 Months | As last reported |
Peer comparison
Biochem Pharmaceutical Industries Limited Part IX is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| NGL Fine-Chem Limited | ₹376.89 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Unicure India Ltd | ₹369.12 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| Beta Drugs Limited | ₹368.79 Cr (FY 2025) | 24.0% | Baddi, Himachal Pradesh, India | |||
| Brawn Laboratories Limited | ₹368.56 Cr (FY 2025) | 15.0% | Delhi, India | |||
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Biochem Pharmaceutical Industries Limited Part IXthis company | ₹366.61 Cr (FY 2016) | ₹11.1 Cr | 3% | 15.0% | Ahmedabad, Gujarat, India | |
| Kopran Research Laboratories Limited | ₹365.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Geltec Private Limited | ₹362.73 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India |
To see the full peer comparison of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2012 | 10373567 | Hdfc Bank Limited | ₹40 Cr | Open | |
| 27 Apr 2006 | 10007694 | Union Bank of India Limited | ₹5.25 Cr | Satisfied | |
| 10 Jan 2006 | 90387783 | Union Bank of India | ₹5 Lakh | Satisfied | |
| 10 Jan 2006 | 80049089 | Union Bank of India | ₹5 Lakh | Satisfied | |
| 07 Jan 2006 | 80049086 | Union Bank of India | ₹1.75 Cr | Satisfied |
To see the full charge records of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Total charge records: 8 View all charges
Legal cases
Biochem Pharmaceutical Industries Limited Part IX has 64 court cases on record: 46 filed by Biochem Pharmaceutical Industries Limited Part IX, 18 filed against it. 8 cases are pending and 56 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 37 | 9 | 8 |
| District courts | 27 | 9 | 0 |
Cases on record (5 of 64)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (NMCD) | Filed by the company against Apex Formulations Pvt. Ltd. and 1 other | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Apex Formulations Pvt. Ltd. and 1 other | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Ronak Life Care Private Limited and Anr | Pending |
| Bombay High Court | Court case (LPETN) | Filed by the company against Apex Formulations Pvt. Ltd. and 1 other | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Health Biotech Ltd | Pending |
To see the full case history of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biochem Pharmaceutical Industries Limited Part IX; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biochem Pharmaceutical Industries Limited Part IX has 28 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Biochem Pharmaceutical Industries Limited Part IX, buy the company report.
Recent activity
Biochem Pharmaceutical Industries Limited Part IX has 22 board changes on record since 2004: 6 appointments and 16 cessations. The latest: Anilkumar Matai ceased to be Additional Director on 05 Aug 2015.
29 earlier events are in the company report.
Frequently asked questions
Biochem Pharmaceutical Industries Limited Part IX has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Biochem Pharmaceutical Industries Limited Part IX was a public limited company based in Ahmedabad, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 04 November 2004 and is registered under CIN U24230GJ2004PLC094323. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Biochem Pharmaceutical Industries Limited Part IX was incorporated on 04 November 2004. It is registered with the Registrar of Companies, Ahmedabad.
Biochem Pharmaceutical Industries Limited Part IX had 6 directors:
- Bhavana Sharadchandra Doshi - Director
- Ganesh Narayan Nayak - Director
- Anilkumar Matai - Director
- Deevyesh Jagjivan Radia - Director
- Mayank Jashwantlal Shah - Director
- Nitinkumar Dalsukhray Parekh - Director
The CIN (Corporate Identification Number) of Biochem Pharmaceutical Industries Limited Part IX is U24230GJ2004PLC094323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Biochem Pharmaceutical Industries Limited Part IX is at Zydustower Satellitecrossroad Sarkhej – Gandhinagarhighway, Ahmedabad, Gujarat, India – 380015.
Biochem Pharmaceutical Industries Limited Part IX can be reached through the website biochemgroup.com. Its registered office is in Ahmedabad, Gujarat, India.
The latest financial statements of Biochem Pharmaceutical Industries Limited Part IX on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 04 August 2016. Year-wise statements from 2015 are in the company report.
No. Biochem Pharmaceutical Industries Limited Part IX has 28 GST registrations on record and all of them are cancelled or inactive.
Biochem Pharmaceutical Industries Limited Part IX operated in the pharma industry, in the drug formulation and development segment.
The peers of Biochem Pharmaceutical Industries Limited Part IX by revenue are NGL Fine-Chem Limited, Unicure India Ltd, Beta Drugs Limited, Brawn Laboratories Limited, M. J. Biopharm Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
